Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer
- PMID: 20082853
- DOI: 10.1016/j.cancergencyto.2009.09.013
Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer
Abstract
Polymorphisms of the TP53 gene codon 72 exhibit less effective function in tumor suppression and usually are associated with human cancer. To investigate the frequency of proline and arginine alleles of TP53 codon 72, the present study analyzed the DNA from blood samples of 30 Iranian women with endometrial cancer, in comparison with 32 healthy women. A Pro/Pro genotype was associated with increased endometrial cancer risk (odds ratio OR = 3.7, 95% confidence interval CI = 0.539-25.59). In patients, Pro allele frequency (68%) was higher than Arg frequency (32%), and higher also than Pro frequency in healthy control subjects (55%) (OR = 1.9, 95% CI = 0.903-3.893). It could be that the Pro allele is less apoptotic than the Arg allele, and that the Arg allele most probably activates transcription factors more efficiently than the Pro variant. These novel findings on the frequency of TP53 gene codon 72 polymorphism in endometrial cancer in Iranian women indicate that in this population the Pro allele might be associated with increased risk of endometrial cancer.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Association of p53 codon 72 Arg>Pro polymorphism and risk of cancer in Iranian population: A systematic review and meta-analysis.Med J Islam Repub Iran. 2017 Dec 27;31:136. doi: 10.14196/mjiri.31.136. eCollection 2017. Med J Islam Repub Iran. 2017. PMID: 29951436 Free PMC article. Review.
-
p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.Gynecol Oncol. 2004 May;93(2):499-505. doi: 10.1016/j.ygyno.2004.02.005. Gynecol Oncol. 2004. PMID: 15099969
-
Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):337-42. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 9162298
-
Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.Cancer Genet Cytogenet. 2007 Feb;173(1):38-42. doi: 10.1016/j.cancergencyto.2006.09.010. Cancer Genet Cytogenet. 2007. PMID: 17284368
-
Prevalence of allelic loss at TP53 in endometrial carcinomas.Oncology. 2010;78(3-4):220-8. doi: 10.1159/000314353. Epub 2010 May 5. Oncology. 2010. PMID: 20453538 Review.
Cited by
-
Endometrial cancer: a genetic point of view.Transl Cancer Res. 2020 Dec;9(12):7706-7715. doi: 10.21037/tcr-20-2334. Transl Cancer Res. 2020. PMID: 35117373 Free PMC article.
-
MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.Hum Cell. 2011 Jun;24(2):57-64. doi: 10.1007/s13577-011-0013-4. Epub 2011 Mar 4. Hum Cell. 2011. PMID: 21547352 Review.
-
Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis.Chronic Dis Transl Med. 2017 May 25;3(2):95-104. doi: 10.1016/j.cdtm.2017.04.001. eCollection 2017 Jun 25. Chronic Dis Transl Med. 2017. PMID: 29063062 Free PMC article.
-
Association of p53 codon 72 Arg>Pro polymorphism and risk of cancer in Iranian population: A systematic review and meta-analysis.Med J Islam Repub Iran. 2017 Dec 27;31:136. doi: 10.14196/mjiri.31.136. eCollection 2017. Med J Islam Repub Iran. 2017. PMID: 29951436 Free PMC article. Review.
-
Investigating the expressions of miRNA-125b and TP53 in endometriosis. Does it underlie cancer-like features of endometriosis? A case-control study.Int J Reprod Biomed. 2020 Oct 13;18(10):825-836. doi: 10.18502/ijrm.v13i10.7767. eCollection 2020 Oct. Int J Reprod Biomed. 2020. PMID: 33134795 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous